Your browser doesn't support javascript.
loading
Toward noninvasive follow-up of low-risk bladder cancer - Rationale and concept of the UroFollow trial.
Benderska-Söder, Natalya; Hovanec, Jan; Pesch, Beate; Goebell, Peter J; Roghmann, Florian; Noldus, Joachim; Rabinovich, Juri; Wichert, Katharina; Gleichenhagen, Jan; Käfferlein, Heiko U; Köhler, Christina U; Johnen, Georg; Kernig, Karoline; Hakenberg, Oliver; Jahn, Daniela; Todenhöfer, Tilman; Stenzl, Arnulf; Gleissner, Jochen; Gerwert, Klaus; El-Mashtoly, Samir; Behrens, Thomas; Brüning, Thomas; Schmitz-Dräger, Bernd J.
Afiliação
  • Benderska-Söder N; Urologie 24, Nürnberg, Germany.
  • Hovanec J; Institute for Prevention and Occupational Medicine of the German Social Accidence Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany.
  • Pesch B; Institute for Prevention and Occupational Medicine of the German Social Accidence Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany.
  • Goebell PJ; Department of Urology, Friedrich-Alexander University, Erlangen, Germany.
  • Roghmann F; Department of Urology, Marienhospital Herne, Ruhr University Bochum, Bochum, Germany.
  • Noldus J; Department of Urology, Marienhospital Herne, Ruhr University Bochum, Bochum, Germany.
  • Rabinovich J; Urologie 24, Nürnberg, Germany.
  • Wichert K; Institute for Prevention and Occupational Medicine of the German Social Accidence Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany.
  • Gleichenhagen J; Institute for Prevention and Occupational Medicine of the German Social Accidence Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany.
  • Käfferlein HU; Institute for Prevention and Occupational Medicine of the German Social Accidence Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany.
  • Köhler CU; Institute for Prevention and Occupational Medicine of the German Social Accidence Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany.
  • Johnen G; Institute for Prevention and Occupational Medicine of the German Social Accidence Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany.
  • Kernig K; Department of Urology, University of Rostock, Rostock, Germany.
  • Hakenberg O; Department of Urology, University of Rostock, Rostock, Germany.
  • Jahn D; Department of Urology, University of Rostock, Rostock, Germany.
  • Todenhöfer T; Department of Urology, Eberhard-Karls-University of Tübingen, Tübingen, Germany.
  • Stenzl A; Department of Urology, Eberhard-Karls-University of Tübingen, Tübingen, Germany.
  • Gleissner J; Die Gesundheitsunion, Wuppertal, Germany.
  • Gerwert K; Ruhr University Bochum, Faculty of Biology and Biotechnology, Department of Biophysics, Bochum, Germany; Ruhr University Bochum, Center for Protein Diagnostics (ProDi), Biospectroscopy, Bochum, Germany.
  • El-Mashtoly S; Ruhr University Bochum, Faculty of Biology and Biotechnology, Department of Biophysics, Bochum, Germany; Ruhr University Bochum, Center for Protein Diagnostics (ProDi), Biospectroscopy, Bochum, Germany.
  • Behrens T; Institute for Prevention and Occupational Medicine of the German Social Accidence Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany.
  • Brüning T; Institute for Prevention and Occupational Medicine of the German Social Accidence Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany.
  • Schmitz-Dräger BJ; Urologie 24, Nürnberg, Germany; Department of Urology, Friedrich-Alexander University, Erlangen, Germany. Electronic address: bernd_sd@yahoo.de.
Urol Oncol ; 38(12): 886-895, 2020 12.
Article em En | MEDLINE | ID: mdl-32199755

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária Idioma: En Ano de publicação: 2020 Tipo de documento: Article